FDA pushes back review deadline for Theratechnologies' tesamorelin

02/25/2010 | Reuters

The FDA postponed its deadline for reviewing Theratechnologies' drug tesamorelin to July 27 after a panel meeting was moved to May 27. The drugmaker submitted tesamorelin for approval to treat excess abdominal fat in HIV-positive patients.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA